UK To Fund ‘Artificial Pancreas’ Technology, But Only For Companies That Cut Prices
Executive Summary
The UK’s health technology assessment organization is in favor of funding hybrid closed loop systems for certain people with type 1 diabetes, but only if companies agree to provide such products at more “cost-effective” prices.
You may also be interested in...
Medtech Monthly, Ep. 4: The Future Of Diabetes Tech
In this edition of the Medtech Monthly podcast, Medtech Insight editor Reed Miller talks to UK-based reporter Barnaby Pickering to get a overview of the highly competitive diabetes tech and future of this dynamic, consumer-centric market.
Medtech Monthly, Ep. 2: Where Does Diabetes Tech Stand In 2022?
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.
Medtronic Remains Aggressive In Diabetes Market, Obtains Two CE Marks
To increase its diabetes care products market share, Medtronic has obtained CE marks for a new continuous glucose monitor and a smart insulin pen.